血管加压素用于心脏术后左、右心异常儿科患者的血管扩张性休克
该研究回顾性分析阜外医院2013年10月至2015年9月70例心脏术后血管扩张性休克儿科患者,多数为右心异常,持续输注血管加压素0.0002–0.002 u/kg/min,比较用药前后血流动力学、尿量和儿茶酚胺剂量。用药2小时后血压显著升高,体循环血管阻力指数从894.3 ± 190.8 dyn/s升至1138.2 ± 161.4 dyn/s per cm per m,心率和右房压、肺动脉压呈下降趋势。随后液体需求和儿茶酚胺需求均减少、尿量增加,乳酸在用药12小时后显著下降。70例均存活至出院。作者认为低剂量血管加压素与及时显著的血流动力学改善相关,未观察到明显不良反应。
要点
- 心脏术后血管扩张性休克儿科患者(多数为右心异常)持续输注血管加压素0.0002–0.002 u/kg/min,2小时后血压显著升高。
- 体循环血管阻力指数从894.3 ± 190.8 dyn/s升至1138.2 ± 161.4 dyn/s per cm per m,心率和右房压、肺动脉压呈下降趋势。
- 用药后液体需求和儿茶酚胺血管加压药需求均减少,尿量增加,乳酸在12小时后显著下降。
- 70例患者均存活至出院,原文报告无明显不良反应。
- 该研究为单中心回顾性分析,纳入连续70例患者。
适用人群与场景
- 心脏术后血管扩张性休克的儿科患者,多数为右心异常;研究纳入阜外医院2013年10月至2015年9月连续70例患者。
处置流程与药物剂量
- 血管加压素持续输注,剂量0.0002–0.002 u/kg/min。
研究设计与关键结果
- 研究类型为单中心回顾性分析,纳入70例心脏术后血管扩张性休克儿科患者,多数为右心异常。
- 血管加压素持续输注0.0002–0.002 u/kg/min,用药2小时后血压显著升高,体循环血管阻力指数从894.3 ± 190.8 dyn/s升至1138.2 ± 161.4 dyn/s per cm per m。
- 用药后心率、右房压、肺动脉压呈下降趋势;液体需求和儿茶酚胺血管加压药需求均减少,尿量增加。
- 乳酸浓度在用药12小时后显著下降;70例患者均存活至出院。
证据类型、等级与局限
- 证据类型:单中心回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于心脏术后血管扩张性休克的儿科患者(包括右心异常者),作者认为低剂量血管加压素(0.0002–0.002 u/kg/min持续输注)与及时显著的血流动力学改善相关,且无明显不良反应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Although the use of vasopressin has become commonplace in pediatric patients with vasodilatory shock after cardiac surgery, its efficacy and hemodynamic effects have not been systematically documented. Furthermore, previous studies were mainly limited patients with left heart anomalies. To date, the use of vasopressin in patients with right heart anomalies has not yet been reported. To clarify the hemodynamic effects of vasopressin on pediatric patients with vasodilatory shock after cardiopulmonary bypass, 70 consecutive patients, most of whom with right heart anomalies, were retrospectively analyzed in Fuwai Hospital from October 2013 to September 2015. Vasopressin was administered continuously at a dose of 0.0002 to 0.002 u/kg/min. Hemodynamics, urine output, and catecholamine vasopressor doses were compared before and after vasopressin initiation. Results showed that besides the significant increase in blood pressure at 2 h after vasopressin administration, the systemic vascular resistance index also prominently elevated from 894.3 ± 190.8 dyn/s to 1138.2 ± 161.4 dyn/s per cm per m, while the heart rate, right atrial pressure, pulmonary artery pressure had a trend of decline. Subsequently, the fluid requirement, the catecholamine vasopressor requirement both decreased and urine output increased. Lactate concentration showed a later remarkable decline at 12 h since vasopressin administration. All the 70 patients survived to hospital discharge. In conclusion, low dose of vasopressin administration was associated with great and timely hemodynamic improvement for pediatric patients with vasodilatory shock after cardiac surgery without any significant adverse effects.
参考来源
- Lu Z, Wang X, Yang J, et al. Vasopressin in Vasodilatory Shock for Both Left and Right Heart Anomalous Pediatric Patients After Cardiac Surgery. Shock. 2018. PMID: 29112103. doi:10.1097/SHK.0000000000001051
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。